Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ferdinando Nicoletti

Showing results (31-40 of 577) with videos related to

Pageof 58
Sort By:
Neurology and Therapy|November 12, 2018
Letter to the Editor Regarding: A Comprehensive Review on Copemyl<sup>®</sup>Giancarlo Comi, Ferdinando Nicoletti, Pier Luigi Canonico, et al.
Drug Design, Development and Therapy|May 31, 2014
Molecular pharmacodynamics of new oral drugs used in the treatment of multiple sclerosisLuigi di Nuzzo, Rosamaria Orlando, Carla Nasca, et al.
Clinical Neuropharmacology|June 11, 2009
Lyrica cures the tenorFerdinando Nicoletti, Roberto Gradini, Pier Francesco Bassi, et al.
CNS Drugs|September 26, 2007
Acetyl-L-carnitine in neuropathic pain: experimental dataSantina Chiechio, Agata Copani, Robert W Gereau, et al.
Cerebellum & Ataxias|September 3, 2015
An update on the cerebellar subtype of multiple system atrophyLudovico Ciolli, Florian Krismer, Ferdinando Nicoletti, et al.
Journal of Molecular Medicine (Berlin, Germany)|April 9, 2009
Molecular mechanisms involved in NAFLD progressionMariano Malaguarnera, Michelino Di Rosa, Ferdinando Nicoletti, et al.
Immunology|September 8, 2011
Vitamin D3: a helpful immuno-modulatorMichelino Di Rosa, Michele Malaguarnera, Ferdinando Nicoletti, et al.
British Journal of Clinical Pharmacology|December 24, 2010
Potential use of rapamycin in HIV infectionMarco Donia, James A McCubrey, Klaus Bendtzen, et al.
Current Drug Targets|April 27, 2017
Potential Use of Modulators of Oxidative Stress as Add-on Therapy in Patients with Anxiety DisordersPaolo Boldrini, Antonella Fusco, Ferdinando Nicoletti, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 18, 2011
Pharmacological activation of group-II metabotropic glutamate receptors corrects a schizophrenia-like phenotype induced by prenatal stress in miceFrancesco Matrisciano, Patricia Tueting, Stefania Maccari, et al.
Pageof 58

Showing results (31-40 of 577) with videos related to

Sort By:
Pageof 58
Neurology and Therapy|November 12, 2018
Letter to the Editor Regarding: A Comprehensive Review on Copemyl<sup>®</sup>Giancarlo Comi, Ferdinando Nicoletti, Pier Luigi Canonico, et al.
Drug Design, Development and Therapy|May 31, 2014
Molecular pharmacodynamics of new oral drugs used in the treatment of multiple sclerosisLuigi di Nuzzo, Rosamaria Orlando, Carla Nasca, et al.
Clinical Neuropharmacology|June 11, 2009
Lyrica cures the tenorFerdinando Nicoletti, Roberto Gradini, Pier Francesco Bassi, et al.
CNS Drugs|September 26, 2007
Acetyl-L-carnitine in neuropathic pain: experimental dataSantina Chiechio, Agata Copani, Robert W Gereau, et al.
Cerebellum & Ataxias|September 3, 2015
An update on the cerebellar subtype of multiple system atrophyLudovico Ciolli, Florian Krismer, Ferdinando Nicoletti, et al.
Journal of Molecular Medicine (Berlin, Germany)|April 9, 2009
Molecular mechanisms involved in NAFLD progressionMariano Malaguarnera, Michelino Di Rosa, Ferdinando Nicoletti, et al.
Immunology|September 8, 2011
Vitamin D3: a helpful immuno-modulatorMichelino Di Rosa, Michele Malaguarnera, Ferdinando Nicoletti, et al.
British Journal of Clinical Pharmacology|December 24, 2010
Potential use of rapamycin in HIV infectionMarco Donia, James A McCubrey, Klaus Bendtzen, et al.
Current Drug Targets|April 27, 2017
Potential Use of Modulators of Oxidative Stress as Add-on Therapy in Patients with Anxiety DisordersPaolo Boldrini, Antonella Fusco, Ferdinando Nicoletti, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 18, 2011
Pharmacological activation of group-II metabotropic glutamate receptors corrects a schizophrenia-like phenotype induced by prenatal stress in miceFrancesco Matrisciano, Patricia Tueting, Stefania Maccari, et al.
Pageof 58